Home Patients Clinical Trials

Clinical Trials

We are driven by science and data

We are driven by science and data

Medical research is critical to drive innovation and scientific advancements that can improve patients’ lives – our mission at Ascendis Pharma. Clinical trials are a fundamental step in this process to develop new therapeutics. As a science-based company, we are committed to conducting clinical trials with the utmost quality and respect for both the clinical trial participants and the scientific hypothesis being evaluated.

We have three endocrinology rare disease product candidates — TransCon™ hGH, TransCon PTH and TransCon CNP – in clinical development. In oncology, we are evaluating a portfolio of product candidates.

Explore below for more about our clinical programs.

ACcomplisH Trial

Trial: ACcomplisH Trial

ACcomplisH: A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Dose Escalation Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 12 months in Prepubertal Children with Achondroplasia

Phase: 2

Status: Ongoing


ACHieve Study

Trial: ACHieve Study

ACHieve: A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia

Phase: Non-interventional (no medication will be given in this study)

Status: Ongoing



We are dedicated to being curious and diligent when innovating, developing
and improving products and processes.


You are about to access www.ascendispharma.com. Click below if you wish to proceed.